Posts by: Marisa Wexler, MS

Marisa Wexler, MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

October 1, 2020October 1, 2020

Relugolix Fails to Delay Castration Resistance in Advanced PC, Trial Shows

News

Relugolix, a form of hormone therapy for prostate cancer, has failed to significantly extend the time men with advanced disease live without acquiring resistance to castration medications, compared with ... Read more

August 31, 2020August 31, 2020

FDA Approves Blood Test That Can Identify Cancers Eligible for Targeted Therapies

News

The U.S. Food and Drug Administration (FDA) has approved FoundationOne Liquid CDx, a blood test that can be used to identify cancer patients who may benefit from certain targeted therapies, ... Read more

August 18, 2020August 18, 2020

Google AI System Outperforms General Pathologists in Grading Prostate Cancers, Study Finds

News

A novel artificial intelligence (AI) technology developed by Google is better at grading prostate cancer biopsies than general pathologists and is as good at identifying cancerous samples, a new study ... Read more

July 28, 2020July 28, 2020

New Guidelines for Care of Advanced Prostate Cancer Released

News

The American Urological Association (AUA), American Society for Radiation Oncology (ASTRO), and Society of Urologic Oncology (SUO) have released new guidelines for the diagnosis and treatment of advanced prostate ... Read more

July 21, 2020July 21, 2020

First AI-based Cancer Detection Application Slated for UK Rollout

News

Ibex Medical Analytics and LDPath have announced the rollout of the first clinical-grade artificial intelligence (AI) applications for pathology-based prostate cancer detection in the U.K. The new apps will aid ... Read more

June 2, 2020June 2, 2020

ADT May Protect Prostate Cancer Patients from COVID-19, Study Suggests

News

Androgen deprivation therapy (ADT), a form of hormone therapy commonly used to treat prostate cancer, appears to confer protection against the virus that causes COVID-19, lowering the rate of ... Read more

April 10, 2020April 24, 2020

Gene Variant Seen to Promote Castration-resistant Disease in Whites

News

A variant in a gene that promotes the production of testosterone by prostate cancer cells is linked to poorer survival and the development of castration-resistant disease in Caucasians with ... Read more

March 27, 2020March 27, 2020

Guidelines for Radiation Therapy with COVID-19 Urge Less Treatment

News

New guidelines for radiation oncologists suggest that, during the COVID-19 pandemic, interactions with healthcare professionals should be done remotely where possible, and treatments should be avoided or delayed to minimize ... Read more

December 11, 2019

Lower Prostate Cancer Risk in Diabetics Likely Due to Fewer Biopsies, Not Medications, Study Says

News

Common treatments for diabetes don’t appear to mask or reduce levels of a prostate cancer marker in the blood. Rather, the lower rates of prostate cancer detected in men ... Read more

November 7, 2019November 11, 2019

Use of Assisted Reproduction Techniques Linked to Increased Prostate Cancer Risk, Study Suggests

News

Men who father children through assisted reproduction techniques, either in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), may be at a higher risk of developing prostate cancer, a ... Read more

Pin It on Pinterest